• Tue, June 29, 2021
  • Mon, June 28, 2021

Raghuram Selvaraju Maintained (AVXL) at Strong Buy with Increased Target to $39 on, Jun 28th, 2021

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Anavex Life Sciences Corp." (AVXL) at Strong Buy with Increased Target from $25 to $39 on, Jun 28th, 2021.

Raghuram, nor any peers, have made any analyst calls on AVXL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30